The global drug eluting balloon market size was valued at US$ 430 Mn in 2018 and is expected to reach US$ 1800 Mn in 2026, expanding at a CAGR of around 18% from 2019 to 2026. The global drug eluting balloon market is anticipated to witness relatively stable growth owing to approvals of expected pipeline of drug eluting balloon and introduction of novel drug eluting balloon-based treatment approaches.
High prevalence of cardiovascular diseases among geriatric population due to adulterated food, booming research & development in treatment of cardiovascular diseases, and developed health care infrastructure are expected to fuel the growth of the global drug eluting balloon market during the forecast period. North America is expected to account for a major share of the global drug eluting balloon market during the forecast period owing to strong presence of major players with established distribution networks in the region. The drug eluting balloon market in Asia Pacific is likely to expand at a significant CAGR from 2019 to 2026.
The report analyzes and forecasts the drug eluting balloon market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of drug eluting balloon, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major drug eluting balloon companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of drug eluting balloon upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of drug eluting balloon and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global drug eluting balloon market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the drug eluting balloon market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of drug eluting balloon market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Major players operating in the global drug eluting balloon market are Medtronic, Becton, Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc, and Biotronik.
The global drug eluting balloon market has been segmented as follows:
Global Drug Eluting Balloon Market, by Product Type
Global Drug Eluting Balloon Market, by Drug Coating Technology
Global Drug Eluting Balloon Market, by End-user
Global Drug Eluting Balloon Market, by Region
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Drug Eluting Balloon Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2018–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Reimbursement Scenario
5.2. Cardiovascular Disease Prevalence
5.3. Key Mergers & Acquisitions
5.4. Key Market Trends
6. Global Drug Eluting Balloon Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2018–2026
6.3.1. Coronary Drug Eluting Balloon
6.3.2. Peripheral Drug Eluting Balloon
6.3.3 Others
6.4. Market Attractiveness, by Product Type
7. Global Drug-Eluting Balloon Market Analysis and Forecast, by Drug Coating Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Drug Coating Technology, 2018–2026
7.3.1. Paccocath
7.3.2. FreePac
7.3.3. TransPax
7.3.4. EnduraCoat
7.3.5. Others
7.4. Market Attractiveness, by Drug Coating Technology
8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2018–2026
8.3.1. Hospitals & Ambulatory Surgical Centers
8.3.2. Cath Labs
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Country/Region
10. North America Drug Eluting Balloon Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2018–2026
10.2.1. Coronary Drug Eluting Balloon
10.2.2. Peripheral Drug Eluting Balloon
10.2.3. Others
10.3. Market Value Forecast, by Drug Coating Technology, 2018–2026
10.3.1. Paccocath
10.3.2. FreePac
10.3.3. TransPax
10.3.4. EnduraCoat
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2018–2026
10.4.1. Hospitals & Ambulatory Surgical Centers
10.4.2. Cath Labs
10.4.3. Others
10.5. Market Value Forecast, by Country, 2018–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Drug Coating Technology
10.6.3. By End-user
10.6.4. By Country
11. Europe Drug Eluting Balloon Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product Type, 2018–2026
11.2.1. Coronary Drug Eluting Balloon
11.2.2. Peripheral Drug Eluting Balloon
11.2.3 Others
11.3.Market Value Forecast, by Drug Coating Technology, 2018–2026
11.3.1. Paccocath
11.3.2. FreePac
11.3.3. TransPax
11.3.4. EnduraCoat
11.3.5. Others
11.4.Market Value Forecast, by End-user, 2018–2026
11.4.1. Hospitals & Ambulatory Surgical Centers
11.4.2. Cath Labs
11.4.3. Others
11.5.Market Value Forecast, by Country/Sub-region, 2018–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Drug Coating Technology
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product Type, 2018–2026
12.2.1. Coronary Drug Eluting Balloon
12.2.2. Peripheral Drug Eluting Balloon
12.2.3. Others
12.3.Market Value Forecast, by Drug Coating Technology, 2018–2026
12.3.1. Paccocath
12.3.2. FreePac
12.3.3. TransPax
12.3.4. EnduraCoat
12.3.5. Others
12.4.Market Value Forecast, by End-user, 2018–2026
12.4.1. Hospitals & Ambulatory Surgical Centers
12.4.2. Cath Labs
12.4.3. Others
12.5.Market Value Forecast, by Country/Sub-region, 2018–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Drug Coating Technology
12.6.3. By End-user
12.6.4. By Country
13. Latin America Drug Eluting Balloon Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product Type, 2018–2026
13.2.1. Coronary Drug Eluting Balloon
13.2.2. Peripheral Drug Eluting Balloon
13.2.3 Others
13.3.Market Value Forecast, by Drug Coating Technology, 2018–2026
13.3.1. Paccocath
13.3.2. FreePac
13.3.3. TransPax
13.3.4. EnduraCoat
13.3.5. Others
13.4.Market Value Forecast, by End-user, 2018–2026
13.4.1. Hospitals & Ambulatory Surgical Centers
13.4.2. Cath Labs
13.4.3. Others
13.5.Market Value Forecast, by Country/Sub-region, 2018–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Drug Coating Technology
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Drug-Eluting Balloon Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Product Type, 2018–2026
14.2.1. Coronary Drug Eluting Balloon
14.2.2. Peripheral Drug Eluting Balloon
14.2.3 Others
14.3.Market Value Forecast, by Drug Coating Technology, 2018–2026
14.3.1. Paccocath
14.3.2. FreePac
14.3.3. TransPax
14.3.4. EnduraCoat
14.3.5. Others
14.4.Market Value Forecast, by End-user, 2018–2026
14.4.1. Hospitals & Ambulatory Surgical Centers
14.4.2. Cath Labs
14.4.3. Others
14.5.Market Value Forecast, by Country/Sub-region, 2018–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Drug Coating Technology
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1.Market Player – Competition Matrix (by Tier and Size of companies)
15.2.Market Share Analysis, by Company (2017)
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Bayer AG
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Product Portfolio
15.4.1.3. SWOT Analysis
15.4.1.4. Strategic Overview
15.4.1.5. Financial Overview
15.4.2. Medtronic
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Product Portfolio
15.4.2.3. SWOT Analysis
15.4.2.4. Strategic Overview
15.4.2.5. Financial Overview
15.4.3. B. Braun Melsungen AG
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Product Portfolio
15.4.3.3. SWOT Analysis
15.4.3.4. Strategic Overview
15.4.3.5. Financial Overview
15.4.4. Cook Medical, Inc.
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Product Portfolio
15.4.4.3. SWOT Analysis
15.4.4.4. Strategic Overview
15.4.4.5. Financial Overview
15.4.5. Boston Scientific Corporation
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Product Portfolio
15.4.5.3. SWOT Analysis
15.4.5.4. Strategic Overview
15.4.5.5. Financial Overview
15.4.6. Becton, Dickinson and Company
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Product Portfolio
15.4.6.3. SWOT Analysis
15.4.6.4. Strategic Overview
15.4.6.5. Financial Overview
15.4.7. EuroCor
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Product Portfolio
15.4.7.3. SWOT Analysis
15.4.7.4. Strategic Overview
15.4.7.5. Financial Overview
15.4.8. Terumo Corporation
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Product Portfolio
15.4.8.3. SWOT Analysis
15.4.8.4. Strategic Overview
15.4.8.5. Financial Overview
15.4.9. Koninklijke Philips N.V
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Product Portfolio
15.4.9.3. SWOT Analysis
15.4.9.4. Strategic Overview
15.4.9.5. Financial Overview
15.4.10. Other Prominent Players
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Product Portfolio
15.4.10.3. SWOT Analysis
15.4.10.4. Strategic Overview
15.4.10.5. Financial Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers